Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anixa Biosciences

3.23
+0.04001.25%
Post-market: 3.300.0700+2.17%15:57 EDT
Volume:38.26K
Turnover:123.37K
Market Cap:104.04M
PE:-8.56
High:3.39
Open:3.19
Low:3.19
Close:3.19
Loading ...

Anixa Biosciences Initiates Fourth Cohort Dosing in Groundbreaking Ovarian Cancer CAR-T Clinical Trial

Reuters
·
23 Jun

Anixa Biosciences Inc - Fourth Cohort Dose Represents Thirtyfold Increase From First Cohort

THOMSON REUTERS
·
23 Jun

Anixa Biosciences Initiates Dosing in Fourth Cohort in Its Ovarian Cancer CAR-T Clinical Trial

THOMSON REUTERS
·
23 Jun

Anixa Biosciences Inc - No Dose-Limiting Toxicities Observed in Third Cohort

THOMSON REUTERS
·
23 Jun

Anixa Biosciences to Host Investor Webcast Featuring CEO Presentation and Q&A Session

Reuters
·
20 Jun

Anixa Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
10 Jun

Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage

THOMSON REUTERS
·
10 Jun

Anixa Biosciences Announces Presentation of Ovarian Cancer CAR-T Clinical Trial Results at ESMO Gynaecological Cancers Congress 2025

Reuters
·
09 Jun

Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the Esmo Gynaecological Cancers Congress 2025

THOMSON REUTERS
·
09 Jun

CEO Amit Kumar Reports Acquisition of Common Shares in Anixa Biosciences Inc

Reuters
·
05 Jun

Promising Developments at Anixa Biosciences: Buy Rating Reiterated with $7 Price Target

TIPRANKS
·
03 Jun

Anixa Biosciences CEO Highlights Breakthrough Breast Cancer Vaccine on NewsNation Interview

Reuters
·
03 Jun

Anixa Biosciences Completes Enrollment in Phase 1 Trial of Breast Cancer Vaccine Funded by U.S. Department of Defense

Reuters
·
02 Jun

Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine

THOMSON REUTERS
·
02 Jun

Anixa Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
29 May

Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th

PR Newswire
·
30 Apr

BRIEF-Anixa Biosciences- Receives Notice Of Allowance For Car-T Technology Patent

Reuters
·
14 Apr

Anixa Biosciences Inc - Receives Notice of Allowance for CAR-T Technology Patent

THOMSON REUTERS
·
14 Apr

Anixa Biosciences Shares Rise After Notice of Patent Allowance for Breast Cancer Vaccine

MT Newswires Live
·
10 Apr

BRIEF-Anixa Biosciences Receives Notice Of Allowance From U.S. Patent And Trademark Office

Reuters
·
09 Apr